These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 5918368)

  • 1. [On the therapy of bronchospastic states in anesthesia. 1-(3-5-Dihydroxyphenyl)-1-hydroxy-2-isopropylaminoethane sulfate].
    Carta M
    Minerva Anestesiol; 1966 Jun; 32(6):315-8. PubMed ID: 5918368
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative bronchodilator effects of inhaled terbutaline aerosols and other beta-adrenergics].
    Roberts M; Petit JM
    Acta Tuberc Pneumol Belg; 1971; 62(2):180-91. PubMed ID: 4398796
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bronchodilating effects of an orciprenaline derivative].
    Anastasatu C; Jienescu Z; Duţu S
    Ftiziologia; 1972; 21(6):593-8. PubMed ID: 4644837
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bronchodilator effect of fenoterol. Duration of activity and use in the basic treatment of bronchospasm].
    Dierckx JP; Gillard C; Gossart R
    Brux Med; 1974 May; 54(5):297-301. PubMed ID: 4429838
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of the bronchospasmolytic activity of alupent and ipradol].
    Makel'skiĭ VV; Iartsev SS
    Sov Med; 1974 Sep; 0(9):142-3. PubMed ID: 4409508
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bronchospasmolytic and extrabronchial action of Berotec (Fenoterol, Th 1165) in patients with asthma or chronic bronchitis with bronchial spasm].
    Rozniecki J; Grabski W
    Pol Tyg Lek; 1975 Feb; 30(7):301-4. PubMed ID: 1118349
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mechanism of action and indications for administration of some bronchodilator agents].
    Nikodýmová L; Růzicka J
    Cas Lek Cesk; 1971 Oct; 110(41):945-50. PubMed ID: 5112128
    [No Abstract]   [Full Text] [Related]  

  • 8. [New adrenaline derivative for the treatment of bronchospasm].
    Antonsen BJ
    Lakartidningen; 1965 Dec; 62():Suppl 2:65-7. PubMed ID: 5868142
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative studies on the effect of Aludrin and Alupent as spray aerosols].
    Fischer M; Mielke U
    Med Klin; 1965 Nov; 60(45):1824-7. PubMed ID: 5887818
    [No Abstract]   [Full Text] [Related]  

  • 10. Metaproterenol, a new bronchodilator:: comparison with isoproterenol.
    Pelz HH
    Am J Med Sci; 1967 Mar; 253(3):321-4. PubMed ID: 6021691
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of spastic bronchitis with a new bronchospasmolytic agent].
    Heller K
    Wien Med Wochenschr; 1972 Oct; 122(42):606-9. PubMed ID: 5081450
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative study of bronchodilating effects and action on the cardiovascular system of 2 sympathomimetic agents: berotec and alupent].
    Zieliński J; Chodosowska E; Koziorowski A
    Gruzlica; 1973 Dec; 41(12):1249-58. PubMed ID: 4774750
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experiences with a new beta 2-receptor stimulant in spastic lung diseases in pediatrics].
    Starnegg Q
    Wien Med Wochenschr; 1971 May; 121(22):455-7. PubMed ID: 5092121
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experiences with a new bronchospasmolytic agent in infancy and childhood].
    Nachtigall C
    Med Monatsschr; 1968 Dec; 22(12):555-7. PubMed ID: 5709425
    [No Abstract]   [Full Text] [Related]  

  • 15. [A new bronchospasmolytic].
    Brunner R
    Arzneimittelforschung; 1972 Jul; 22(7):1223-5. PubMed ID: 4678135
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bronchospastic states in childhood].
    Wilk F
    Wien Klin Wochenschr; 1971 Feb; 83(6):98-101. PubMed ID: 5101281
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of orciprenaline in the treatment of bronchospastic conditions].
    Semczuk B; Klonowski S; Czerwonka R; Golabek W; Czarnecki J; Czop S; Suwala H
    Pol Tyg Lek; 1974 Apr; 29(17):729-32. PubMed ID: 4830959
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the treatment of bronchospastic ventilation disorders and respiratory insufficiency].
    Friedrich R
    Med Monatsschr; 1965 Jun; 19(6):277-9. PubMed ID: 5318642
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative clinical study of KWD 2019, terbutaline, and adrenaline administered subcutaneously to respiratory insufficiency patients].
    Verstraeten JM
    Acta Tuberc Pneumol Belg; 1971; 62(2):192-203. PubMed ID: 5112904
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of bronchospastic component in patients with chronic pneumonia].
    Sviridov AA; Gavrilov VV
    Sov Med; 1975 Aug; (8):81-3. PubMed ID: 1198193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.